Personal information

Activities

Works (2)

Datopotamab deruxtecan versus docetaxel in previously treated advanced or metastatic non-small cell lung cancer: A cost-effectiveness analysis

Lung Cancer
2024-08 | Journal article
Contributors: Chenfeng Tan; Jiaqi Han; Bin Zeng; Zhongzheng Xiang; Yuanyuan Zeng; Jun Wang; Xiaoyuan Wei; Zelei Dai; Ningyue Xu; Wenju Xiong et al.
Source: check_circle
Crossref

Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis

Oral Oncology
2022-05 | Journal article
Contributors: Kun Tian; Jiaqi Han; Zhu Wang; Jie Chen
Source: check_circle
Crossref